Top 5 Dementia: this caregiver-focused guide explains what top 5 dementia means in plain English, the day-to-day implications for families, and when to bring it up with a clinician. If you arrived here looking for a quick orientation on top 5 dementia, the table of contents below points to the section you need; the full guide picks up after it.
For a broader overview, see our dementia treatment and medications guide.
Table of contents
- Sources used for this Top 5 Dementia guide
The Top 5 Dementia Drugs Ranked by Effectiveness (Simplified Guide)
Dementia treatments have evolved significantly, with newer drugs showing promise in slowing cognitive decline. Here’s a straightforward breakdown of the top 5 most effective options based on recent research:
1. Donanemab
Effectiveness: Topping the list, donanemab nearly doubles the benefits of similar drugs like aducanumab and lecanemab. It helps patients retain cognitive and daily functioning longer, with studies showing it takes just 10 people on this drug to prevent noticeable decline in one person[3][5].
Risks: Higher chance of brain swelling or microbleeds (about 1 in 8 users)[3].
2. Lecanemab
Effectiveness: Slows early Alzheimer’s progression by targeting amyloid plaques. While less potent than donanemab, it still shows meaningful delays in memory loss[2][3].
Risks: Brain swelling occurs in roughly 1 out of every 14 patients[3].
3. Aducanumab
Effectiveness: The first FDA-approved anti-amyloid drug for Alzheimer’s, but its benefits are modest compared to newer options[1][3]. Works best when started early.
Risks: Similar safety concerns—brain swelling affects about 1 in 10 users[3].
4. Statins (e.g., Atorvastatin)
While not traditional dementia drugs, statins show surprising links to reduced Alzheimer’s risk[4]. Their role isn’t fully understood yet but offers hope for future research into cholesterol-related therapies[4].
Honorable Mention: Older Medications (Donepezil/Rivastigmine)
These long-used cholinesterase inhibitors help manage symptoms like memory lapses but don’t slow disease progression like newer anti-amyloid drugs[^general_knowledge]. Often prescribed alongside lifestyle changes.
Key Takeaway: Safety vs Benefits Trade-Off
The most effective drugs—donanemab, lecanemab, and aducanumab—all carry risks of brain swelling or bleeding[1][3][5], requiring careful monitoring through regular brain scans during treatment.
Note: Always consult doctors before starting/changing medications.
Sources used for this Top 5 Dementia guide
- National Institute on Aging — Alzheimer’s and related dementias
- Alzheimer’s Association
- Mayo Clinic — Dementia
This article is informational and not medical advice. See our Editorial Policy for how we research and review content. Last reviewed May 30, 2026.



